Sex Hormone Levels, Breast Cancer Risk, and Cancer Receptor Status in Postmenopausal Women: the ORDET Cohort

被引:96
|
作者
Sieri, Sabina [1 ]
Krogh, Vittorio [1 ]
Bolelli, Gianfranco [7 ]
Abagnato, Carlo Alberto [7 ]
Grioni, Sara [1 ]
Pala, Valeria [1 ]
Evangelista, Alberto [1 ]
Allemani, Claudia [2 ]
Micheli, Andrea [3 ]
Tagliabue, Giovanna [4 ]
Schunemann, Holger J. [8 ]
Menard, Sylvie [5 ]
Berrino, Franco [6 ]
Muti, Paola [8 ]
机构
[1] Fdn IRCCS Ist Nazl Tumori, Nutr Epidemiol Unit, I-20133 Milan, Italy
[2] Fdn IRCCS Ist Nazl Tumori, Analyt Epidemiol Unit, I-20133 Milan, Italy
[3] Fdn IRCCS Ist Nazl Tumori, Descript Epidemiol & Hlth Planning Unit, I-20133 Milan, Italy
[4] Fdn IRCCS Ist Nazl Tumori, Canc Registry Div, I-20133 Milan, Italy
[5] Fdn IRCCS Ist Nazl Tumori, Labs & Dept Expt Oncol, Mol Biol Unit, I-20133 Milan, Italy
[6] Fdn IRCCS Ist Nazl Tumori, Etiol & Prevent Epidemiol Unit, I-20133 Milan, Italy
[7] Ctr Med Diagnost Emilia, Bologna, Italy
[8] Ist Regina Elena, Epidemiol & Prevent Unit, I-00161 Rome, Italy
关键词
METABOLIC-SYNDROME; ESTROGEN-RECEPTOR; GENE-EXPRESSION; ENDOGENOUS ESTROGENS; PROGESTERONE; ANDROGEN; TESTOSTERONE; CARCINOMAS; GROWTH;
D O I
10.1158/1055-9965.EPI-08-0808
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Endogenous sex hormone levels have been associated with increased breast cancer risk in postmenopausal women in several prospective studies. However, it remains unclear to what extent serum hormone-breast cancer associations differ with receptor status. Methods: Associations between serum sex hormone levels and breast cancer risk were assessed in a nested case-control study on postmenopausal women of the ORDET cohort. After a median follow-up of 13.5 years, 1.65 women developed breast cancer. Relative risks of developing breast cancer were estimated by conditional logistic regression. Results: Total and free testosterone levels were directly associated with breast cancer risk [relative risk, 3.28 (95% confidence interval, 1.93-5.55) and 2.86 (95% confidence interval, 1.66-4.94), respectively, for highest versus lowest quartile]. When relations between hormone level and risk of breast cancer expressing various receptor combinations were assessed, high total testosterone was significantly associated with increased risk of estrogen receptor-positive cancers, irrespective of progesterone receptor status. High total testosterone was also associated with increased risk of both human epidermal growth factor receptor 2 (HER2)-negative (HER2(-)) and HER2(+) cancers. High estradiol tended to be associated with increased risk of HER2- cancer and inversely associated with HER2(+) cancer, with significant (P = 0.027) heterogeneity between HER2(+) and HER2- cancers. However, there were relatively few HER2(+) cases. Conclusions: This study provides further evidence that high levels of circulating testosterone increase the risk of developing breast cancer in postmenopausal women. The cancers that develop are mainly estrogen receptor positive. Although HER2(+) and HER2- breast cancers were both associated with high total testosterone, they showed opposing associations with estrogen. (Cancer Epidemiol Biomarkers Prev 2009;18(1):169-76)
引用
收藏
页码:169 / 176
页数:8
相关论文
共 50 条
  • [31] Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women
    Tamimi, Rulla M.
    Byrne, Celia
    Colditz, Graham A.
    Hankinson, Susan E.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (15): : 1178 - 1187
  • [32] Relation of serum levels of estrogen and dehydroepiandrosterone sulfate to hormone receptor status among postmenopausal women with breast cancer.
    Kakugawa Y.
    Minami Y.
    Tateno H.
    Inoue H.
    Fujiya T.
    Breast Cancer, 2007, 14 (3) : 269 - 276
  • [33] Sex Hormone Concentrations and the Risk of Breast Cancer Recurrence in Postmenopausal Women without Hot Flashes
    Emond, Jennifer A.
    Patterson, Ruth E.
    Natarajan, Loki
    Laughlin, Gail A.
    Gold, Ellen B.
    Pierce, John P.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2011, 20 (05) : 939 - 945
  • [34] PROSPECTIVE COHORT STUDY OF POSTMENOPAUSAL HORMONE USE AND RISK OF BREAST-CANCER IN US WOMEN
    PETITTI, DB
    PERLMAN, JA
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 1988, 127 (04) : 883 - 883
  • [35] Food Sources of Fat and Sex Hormone Receptor Status of Invasive Breast Tumors in Women of the Malmo Diet and Cancer Cohort
    Wirfalt, Elisabet
    Li, Cairu
    Manjer, Jonas
    Ericson, Ulrika
    Sonestedt, Emily
    Borgquist, Signe
    Landberg, Goran
    Olsson, Hakan
    Gullberg, Bo
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2011, 63 (05): : 722 - 733
  • [36] Effect of anastrozole on hormone levels in postmenopausal women with early breast cancer
    Kyvernitakis, I.
    Albert, U-S.
    Kalder, M.
    Winarno, A-S.
    Hars, O.
    Hadji, P.
    CLIMACTERIC, 2015, 18 (01) : 63 - 68
  • [37] Cyp17, urinary sex steroid levels and breast cancer risk in postmenopausal women
    Onland-Moret, NC
    van Gils, CH
    Roest, M
    Grobbee, DE
    Peeters, PHM
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (04) : 815 - 820
  • [38] Risk factors for postmenopausal breast cancer defined by estrogen and progesterone receptor status: The multiethnic cohort
    Setiawan, Veronica
    Monroe, Kristine
    Wilkens, Lynne
    Kolonel, Laurence
    Pike, Malcolm
    Henderson, Brian
    CANCER RESEARCH, 2008, 68 (09)
  • [39] Sunlight, hormone replacement status and colorectal cancer risk in postmenopausal women
    Freedman, D. Michal
    Rajaraman, Preetha
    Fuhrman, Barbara
    Hoffbeck, Richard
    Alexander, Bruce H.
    INTERNATIONAL JOURNAL OF CANCER, 2010, 126 (08) : 1997 - 2001
  • [40] Serum sex hormone levels in pre- and postmenopausal breast cancer patients
    Ho, C. C. K.
    Rohaizak, M.
    Zulkifli, S. Z.
    Siti-Aishah, M. A.
    Nor-Aini, U.
    Sharifah-Noor-Akmal, S. H.
    SINGAPORE MEDICAL JOURNAL, 2009, 50 (05) : 513 - 518